- Home
- AXGN vs CRMD Comparison
AXGN vs CRMD Comparison
Compare AXGN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- CRMD
- Stock Information
- Founded
- AXGN N/A
- CRMD 2006
- Country
- AXGN United States
- CRMD United States
- Employees
- AXGN N/A
- CRMD N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- AXGN Health Care
- CRMD Health Care
- Exchange
- AXGN Nasdaq
- CRMD Nasdaq
- Market Cap
- AXGN 804.8M
- CRMD 871.9M
- IPO Year
- AXGN N/A
- CRMD 2010
- Fundamental
- Price
- AXGN $23.44
- CRMD $10.79
- Analyst Decision
- AXGN Strong Buy
- CRMD Strong Buy
- Analyst Count
- AXGN 7
- CRMD 7
- Target Price
- AXGN $27.71
- CRMD $17.86
- AVG Volume (30 Days)
- AXGN 889.9K
- CRMD 2.5M
- Earning Date
- AXGN 10-29-2025
- CRMD 11-12-2025
- Dividend Yield
- AXGN N/A
- CRMD N/A
- EPS Growth
- AXGN N/A
- CRMD N/A
- EPS
- AXGN N/A
- CRMD 0.79
- Revenue
- AXGN $214,709,000.00
- CRMD $121,484,498.00
- Revenue This Year
- AXGN $21.57
- CRMD $565.64
- Revenue Next Year
- AXGN $15.79
- CRMD $46.09
- P/E Ratio
- AXGN N/A
- CRMD $13.60
- Revenue Growth
- AXGN 18.72
- CRMD 14970.29
- 52 Week Low
- AXGN $9.22
- CRMD $5.60
- 52 Week High
- AXGN $24.25
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- AXGN 72.25
- CRMD 43.69
- Support Level
- AXGN $23.19
- CRMD $10.87
- Resistance Level
- AXGN $24.25
- CRMD $11.68
- Average True Range (ATR)
- AXGN 1.15
- CRMD 0.61
- MACD
- AXGN 0.47
- CRMD -0.00
- Stochastic Oscillator
- AXGN 86.87
- CRMD 12.63
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.